Bristol Gate Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bristol Gate Capital Partners's LLY Position: Q3 2026 in Review
Bristol Gate Capital Partners reduced its Eli Lilly (LLY) stake by 1.5% in Q3 2026, selling an estimated $1.13M and leaving 61,388 shares worth $71M. The position accounts for 5.23% of the portfolio, ranked #1.
Bristol Gate Capital Partners first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $97.7M in Q1 2025. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bristol Gate Capital Partners held 61,388 shares of Eli Lilly worth $71M as of Q3 2026.
- Bristol Gate Capital Partners sold 957 Eli Lilly shares in Q3 2026, an estimated $1.13M.
- Eli Lilly made up 5.23% of Bristol Gate Capital Partners's portfolio in Q3 2026, its #1 holding.
- Bristol Gate Capital Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
- Bristol Gate Capital Partners's Eli Lilly position peaked at $97.7M in Q1 2025.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bristol Gate Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.